Should benefit–risk assessment have its own drug “label”?
Braithwaite, R. ScottLanguage:
english
Journal:
Drug, Healthcare and Patient Safety
DOI:
10.2147/dhps.s21927
Date:
August, 2011
File:
PDF, 166 KB
english, 2011